Influenza Prevention: Exploring the Progress and Persevering through Challenges

Dear Colleagues,

Influenza is a viral infection accountable for seasonal epidemics worldwide, leading to a considerable disease burden throughout the world. The infection can trigger mild symptoms, but also causes severe complications, resulting in hospitalization or even death.

It is well known that seasonal influenza vaccination is among the most effective public health means to prevent and reduce the epidemiological, clinical, socio-economic burden of disease.

As recommended by the World Health Organization (WHO), it is important to expand immunization programs for seasonal influenza vaccination for the following target populations: healthcare workers, individuals with comorbidities and underlying medical conditions, older adults, pregnant women, children, and other groups at a high risk of severe influenza in congregate-living settings. Despite its proven effectiveness and policy recommendations, seasonal influenza vaccination coverage rates in most industrialized countries are still low. Increasing seasonal vaccination within priority groups is a key strategy to lessen the burden of influenza.

This Special Issue focuses on the importance of influenza prevention in human health, and the advances in research leading to the development of better preventive strategies, exploring the latest innovations and challenges in tackling this important health issue.

Dr. Filippo Ansaldi
Dr. Daniela Amicizia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• vaccine
• immunization
• preventive strategies
• influenza